Exelixis, Inc. (EXEL)

Exelixis Market Cap

Exelixis has a market cap or net worth of $6.58 billion as of July 22, 2024. Its market cap has increased by 4.59% in one year.

• Market Cap: 6.58B
• Enterprise Value: 5.82B
• 1-Year Change: 4.59%
• Ranking: #1096
• Category: Mid-Cap
• Stock Price: $22.60

Market Cap Chart

Since April 17, 2000, Exelixis's market cap has increased from $630.80M to $6.58B, an increase of 943.63%. That is a compound annual growth rate of 10.15%.

Market Cap History

Date	Market Cap	% Change
Jul 19, 2024	6.58B	-11.76%
Dec 29, 2023	7.46B	44.19%
Dec 30, 2022	5.17B	-10.54%
Dec 31, 2021	5.78B	-7.11%
Dec 31, 2020	6.23B	16.30%
Dec 31, 2019	5.35B	-8.96%
Dec 31, 2018	5.88B	-34.61%
Dec 29, 2017	8.99B	110.58%
Dec 30, 2016	4.27B	233.29%
Dec 31, 2015	1.28B	355.89%
Dec 31, 2014	281.10M	-75.11%
Dec 31, 2013	1.13B	34.59%
Dec 31, 2012	839.00M	36.62%
Dec 30, 2011	614.10M	-31.37%
Dec 31, 2010	894.80M	13.07%
Dec 31, 2009	791.40M	49.29%
Dec 31, 2008	530.10M	-41.23%
Dec 31, 2007	902.00M	4.64%
Dec 29, 2006	862.00M	10.08%
Dec 30, 2005	783.10M	10.19%
Dec 31, 2004	710.70M	41.83%
Dec 31, 2003	501.10M	9.05%
Dec 31, 2002	459.50M	-44.16%
Dec 31, 2001	822.90M	25.02%
Dec 29, 2000	658.20M	4.34%

View and export this data all the way back to 2000. Sign Up Today.

Related Stocks

Company	Market Cap
Ionis Pharmaceuticals	6.98B
Repligen	6.92B
Halozyme Therapeutics	6.88B
Jazz Pharmaceuticals	6.87B
Tempus AI	6.82B
Cytokinetics	6.47B
HealthEquity	6.38B
Grifols	6.30B